| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
DermTech (NASDAQ:DMTK) reported its Q4 earnings results on Thursday, February 29, 2024 at 04:01 PM.
Here's what investors need to know about the announcement.
DermTech missed estimated earnings by 0.0%, reporting an EPS of $-0.56 versus an estimate of $-0.56.
Revenue was up $930 thousand from the same period last year.
Last quarter the company beat on EPS by $0.19 which was followed by a 6.0% increase in the share price the next day.
Here's a look at DermTech's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.76 | -0.95 | -0.91 | -0.96 |
| EPS Actual | -0.57 | -0.99 | -1.02 | -0.93 |
| Revenue Estimate | 3.90M | 3.55M | 3.47M | 2.56M |
| Revenue Actual | 3.92M | 3.56M | 3.48M | 2.99M |
To track all earnings releases for DermTech visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: DMTK
